Skip to content

A randomized controlled trial to asses the effect of topical vitamin D in patients with atopic dermatitis.

A randomized controlled trial to asses the effect of topical vitamin D in patients with atopic dermatitis. - Atopic dermatitis and vitamin D

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35970
Enrollment
100
Registered
2012-02-16
Start date
2012-03-21
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic eczema

Interventions

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age 18 years or older. Mild to moderate atopic dermatitis, with a SCORAD score between 15 and 40. Informed consent

Exclusion criteria

Exclusion criteria: -Oral use of prescribed vitamin D or calcium supplements. -Pregnancy -Lactating women -Patients who receive specialized treatment for disorders in calcium homeostasis and/or liver and kidney diseases. -Inflammatory skin diseases unrelated to atopic dermatitis, except acneiform eruption. -Sunny holiday during the previous 6 weeks -Use of sunbeds or UV-therapy. -Allergy/intolerance for ingredients used in the study medications. -Previously documented non-compliance.

Design outcomes

Primary

MeasureTime frame
Main endpoint will be the number of, and time to, exacerbation of atopic dermatitis. To assess a profile of which patients are better to treatable with topical vitamin D, filaggrin mutation and vitamin D levels at the start of treatment will be assessed.

Secondary

MeasureTime frame
The quality of life in patients using the different treatment and the difference of transepidermal water loss between the two treatment groups.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)